1. Recent Funding
2. Investors
3. BrightEdge - American Cancer Society

B

BrightEdge - American Cancer Society

BrightEdge - American Cancer Society has backed 1 company on Recent Funding, 1 in the last 12 months; its most recent deal is Cloverleaf Bio (2026-09-08).

What BrightEdge - American Cancer Society invests in

• Health and bio · 1 · 100%

How BrightEdge - American Cancer Society invests

Share is of the 1 round on Recent Funding that name BrightEdge - American Cancer Society. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio

Company	Round with BrightEdge - American Cancer Society	Total raised	Latest raise
CCloverleaf Bio Health and bio	Sep 8, 2026 seed · $33M	$33M	Sep 8, 2026 seed

Most frequent co-investors

• DDraper Associates1 shared round · last Sep 8, 2026
• EEli Lilly1 shared round · last Sep 8, 2026
• MMission BioCapital1 shared round · last Sep 8, 2026
• BBoehringer Ingelheim Venture Fund1 shared round · last Sep 8, 2026
• AAbbVie1 shared round · last Sep 8, 2026
• 44BIO Capital1 shared round · last Sep 8, 2026

Portfolio companies are the companies on Recent Funding with a round that lists BrightEdge - American Cancer Society, which is a subset of its real portfolio. API: /api/v1/investors/brightedge-american-cancer-society. All investors.